Form 4: USANA Health Sciences CEO Jim Brown Reports Routine Stock Transactions

USANA Health Sciences CEO and President Jim Brown reported the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Summary

• Jim Brown, CEO & President of USANA Health Sciences Inc. (USNA), reported transactions on July 24, 2025.
• Acquired 2,190 shares of common stock through the vesting of Restricted Stock Units (RSUs).
• Disposed of 972 shares of common stock at a price of $32.09 per share, likely to satisfy tax withholding obligations related to the RSU vesting.
• Following these transactions, Jim Brown beneficially owns 16,934 shares of common stock directly.
• The vesting event involved 2,190 Restricted Stock Units, which converted into common stock.
• After the RSU vesting, 160,878 derivative securities (Restricted Stock Units) remain beneficially owned directly.

Sentiment

Score: 5

Explanation: The filing reports routine, pre-scheduled compensation-related stock transactions for the CEO, which are neutral in sentiment. There are no unexpected positive or negative developments.

Positives

• The vesting of Restricted Stock Units indicates a scheduled compensation event for the CEO, aligning management's interests with shareholder value over time.
• The acquisition of 2,190 shares through RSU vesting increases the CEO's direct ownership before the tax-related sale.

Negatives

• The disposition of 972 shares, even for tax purposes, reduces the CEO's direct beneficial ownership of common stock.

Future Outlook

The filing does not provide forward-looking statements or guidance beyond the details of the reported transactions.

Industry Context

This Form 4 filing details a routine insider transaction related to executive compensation, which is common across all industries for publicly traded companies. It does not provide specific insights into broader industry trends for the health sciences sector.

Stakeholder Impact

• Shareholders: The transaction is a routine compensation event and does not indicate a significant change in company strategy or financial health. The CEO's ownership remains substantial.
• Employees: No direct impact on employees is indicated by this filing.

Next Steps

• Future vesting events for the remaining 160,878 Restricted Stock Units are expected to occur on subsequent anniversaries of July 24, 2023, as RSUs vest 25% annually.

Key Dates

Keywords

USANA Health Sciences, USNA, Jim Brown, CEO, Restricted Stock Units, RSU, Insider Trading, Stock Transaction, Form 4, Beneficial Ownership